Particularly, high-level resistant isolates rose from 5.26% (3/57) in the low epidemic phase to 27.6% (8/29) at epidemic initiation, declined to 6.45% (2/31) in the ultra-low epidemic phase, and then exhibited an increasing trend, reaching 14.1% (9/64) in the outbreak phase and 31.25% (5/16) in the recovery phase.
← all excerpts
Antimicrobial Susceptibility and Distribution Characteristics of <i>Mycoplasma pneumoniae</i> Isolates in Beijing, China, from 2017 to 2025.
1
—
—